You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南新制藥(688189.SH):湘投集團擬無償劃轉公司28.57%股權至新組建的醫藥發展集團
格隆匯 09-04 16:05

格隆匯9月4日丨南新制藥(688189.SH)公佈,公司於2022年9月4日收到公司控股股東湖南湘投控股集團有限公司(“湘投集團”)通知,獲悉湘投集團擬將其持有公司28.57%股權(5600萬股)無償劃轉至新組建的湖南醫藥發展投資集團有限公司(“醫藥發展集團”)。

截至公吿披露日,此次無償劃轉的劃入方湖南醫藥發展投資集團有限公司仍在組建當中。

此次權益變動屬於國有股權無償劃轉,公司控股股東由湘投集團變更為醫藥發展集團,實際控制人未發生變化,仍為湖南省人民政府國有資產監督管理委員會。此次無償劃轉不會對公司的正常生產經營活動產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account